U.S. Water Utilities Stock News

NYSE:NVST
NYSE:NVSTMedical Equipment

Envista Holdings Growth Push Pressures Returns And Market Share Prospects

Envista Holdings, NYSE:NVST, is seeing weaker returns on capital from its recent growth push. The company is finding it harder to defend market share in core dental equipment and technology lines. These shifts are raising questions about the durability of its traditional profit engines. Envista Holdings, NYSE:NVST, sits at a current share price of $23.47 after a mixed run, with the stock up 14.4% over the past year but down 43.0% over three years and 37.7% over five years. That kind of...
NYSE:TAL
NYSE:TALConsumer Services

Assessing TAL Education Group (TAL) After Shares Rally And Regulatory Reset

If you are wondering whether TAL Education Group's current share price reflects its true worth, you are not alone. This article is built to help you put a number around that question. The stock last closed at US$12.70, with returns of 13.5% over 7 days, 16.4% over 30 days, 10.5% year to date, 3.8% over 1 year, 87.3% over 3 years and an 84.2% decline over 5 years. Recent news around TAL has focused on the company finding its footing within China's evolving after school tutoring rules and...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

A Look At Flywire (FLYW) Valuation After Recent Share Price Weakness

Recent performance snapshot Flywire (FLYW) has drawn investor attention after a stretch of weaker share performance, with the stock showing a 2.4% decline over the past day and a 34.8% decline over the past year. Over the past month, Flywire has recorded an 11.0% decline. The past 3 months show a 5.4% decline and the year-to-date return is a 9.4% decline, all measured against a last close of US$12.60. See our latest analysis for Flywire. For Flywire, the weak 1 year total shareholder return...
NYSE:SNDR
NYSE:SNDRTransportation

Schneider National (SNDR) Margin Compression To 1.8% Tests Bullish Earnings Growth Narrative

Schneider National (SNDR) has wrapped up FY 2025 with fourth quarter revenue of US$1.4 billion and basic EPS of US$0.13, alongside net income of US$22.1 million. This sets the tone for a year where trailing twelve month revenue reached US$5.7 billion and EPS came in at US$0.59. Over recent quarters the company has reported revenue in a range between US$1.3 billion and US$1.5 billion, with quarterly EPS moving between roughly US$0.11 and US$0.21. For investors, the key question now is how...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Is IDEAYA Biosciences (IDYA) Pricing Reflect Its DCF Upside After Recent Share Pullback

If you are wondering whether IDEAYA Biosciences is trading at a fair price or not, you are in the right place because this article focuses squarely on what you are paying versus what you are getting. Despite some recent volatility, with the share price at US$32.19 and returns of 7.5% decline over 7 days, 6.9% decline over 30 days and 4.9% decline year to date, the stock still shows a 32.2% return over 1 year, 83.3% over 3 years and 67.2% over 5 years. Recent company specific developments and...
NYSE:GME
NYSE:GMESpecialty Retail

GameStop Targets Larger Consumer Deal As Cohen Pursues Conglomerate Future

GameStop (NYSE:GME) has announced plans to acquire a much larger publicly traded consumer company as part of a pivot toward a diversified conglomerate model. CEO Ryan Cohen is leading the effort, backed by a new performance-based pay plan and support from high-profile investors, including Michael Burry. The company cites its liquidity position as a key resource for pursuing this transformational deal, which would significantly expand GameStop's scale and industry reach. For investors, this...
NYSE:USB
NYSE:USBBanks

How Earnings Growth, Buybacks and New Debt Issuance Will Impact U.S. Bancorp (USB) Investors

U.S. Bancorp recently reported higher fourth-quarter and full-year 2025 earnings, continued share repurchases under its existing buyback program, and issued a series of new senior notes spanning 2032 to 2046 with both fixed and variable coupons. The bank is also undergoing a planned leadership transition, with CEO and President Gunjan Kedia set to become chair in April 2026 and longtime executive Souheil Badran retiring after helping embed automation and artificial intelligence across...
NYSE:CL
NYSE:CLHousehold Products

Colgate-Palmolive’s 2030 Plan Weighs Latin America Rebound And Pet Nutrition

Colgate-Palmolive (NYSE:CL) has set out a 2030 company plan focused on brands, product development, digital tools and supply chain efficiency. The plan comes alongside a turnaround in Latin America following earlier product issues in the region. The company is putting extra weight behind Hill’s pet nutrition and recent acquisitions, while its skin health unit faces weaker conditions, particularly in China. For investors watching consumer staples, Colgate-Palmolive sits in the spotlight with...
NYSE:KMX
NYSE:KMXSpecialty Retail

Should Giverny Capital’s Exit Over Omnichannel Payoff Concerns Require Action From CarMax (KMX) Investors?

Giverny Capital Asset Management disclosed in its fourth-quarter 2025 investor letter that it had fully exited its long-term holding in CarMax, criticizing management for not adjusting effectively to a tougher used car market marked by expensive vehicles, higher financing costs, and limited supply of 2–5 year-old cars. The move underscores how even long-term institutional holders can lose confidence when a retailer’s costly investments, such as CarMax’s omnichannel platform, fail to...
NYSE:LVS
NYSE:LVSHospitality

Is Las Vegas Sands (LVS) Pricing Looked At Again After Recent Share Price Slide?

If you are wondering whether Las Vegas Sands is attractively priced or not, starting with a clear view of its current valuation can help you decide how it might fit into your portfolio. The stock closed at US$52.73, with a 12% decline over the past 7 days and a 19% decline over the past 30 days, while the 1 year return sits at 17.5% and the 3 year and 5 year returns are 4.9% and 0.6% declines respectively. Recent coverage has focused on Las Vegas Sands as a large US listed casino and resort...
NYSE:TRV
NYSE:TRVInsurance

How Investors May Respond To Travelers (TRV) Earnings Beat, Higher Dividend And Larger Buyback Authorization

The Travelers Companies, Inc. reported full-year 2025 revenue of US$48.83 billion and net income of US$6.29 billion, while affirming a US$1.10 quarterly dividend and expanding its share repurchase authorization by US$5.00 billion. Together with its earnings release, Travelers’ decision to increase its long-running buyback program underscores management’s focus on sustained capital returns to shareholders. Next, we’ll examine how Travelers’ combination of earnings growth and an expanded...
NYSE:LPG
NYSE:LPGOil and Gas

Evaluating Dorian LPG (LPG) After Strong Recent Returns And A Suggested 7.7% Valuation Discount

DorianG (LPG) has drawn investor attention after recent trading left the shares with a year-to-date return of 19.3% and a 1-year total return of 35.0%, prompting closer scrutiny of its fundamentals. See our latest analysis for DorianG. The recent 21.32% 1 month share price return, compared with a more modest 2.36% 3 month share price return, suggests momentum has picked up again around DorianG, while the 5 year total shareholder return of 381.35% highlights how powerful compounding has been...
NYSE:TGNA
NYSE:TGNAMedia

Will TEGNA's (TGNA) Mobile App Push and Award-Winning Journalism Deepen Its Local-Media Moat?

TEGNA Inc. recently rolled out new personalized local news and weather apps across 50 markets and saw audience engagement climb, while its Atlanta NBC affiliate WXIA (11Alive) won the 2026 Alfred I. duPont-Columbia University Award for the “Help That Harms” investigation that drove statewide policy reforms in Georgia. Together, the surge in mobile usage and high-profile recognition for impactful journalism underscore TEGNA’s strengthening connection with local audiences and public...
NYSE:TT
NYSE:TTBuilding

Trane Technologies (TT) Is Up 8.9% After AI-Driven HVAC Demand Fuels Record Backlog And Guidance

In late January 2026, Trane Technologies reported fourth-quarter 2025 results showing sales of US$5,144.5 million and diluted EPS from continuing operations of US$2.74, alongside guidance for full-year 2026 reported revenue growth of about 8.5% to 9.5% and adjusted EPS of US$14.65 to US$14.85. Management highlighted exceptional Q4 enterprise organic bookings up 22%, a record US$7.8 billion backlog, and rising demand for commercial HVAC solutions serving AI data centers, supported by...
NYSE:SPHR
NYSE:SPHREntertainment

Sphere Entertainment Tests Smaller Sphere Model With Maryland National Harbor Plan

Sphere Entertainment (NYSE:SPHR) announced plans for a new venue at National Harbor in Maryland, its second U.S. location. The project will use a smaller scale design compared with the company’s existing U.S. venue. The development is expected to bring Sphere’s immersive entertainment concept to the Washington, D.C. metropolitan area. Company communications highlight anticipated economic, cultural, and community impacts, including job creation and public private investment. Sphere...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

Is First Merchants (FRME) Pricing Look Attractive After Recent Regional Bank Sector Focus

If you are wondering whether First Merchants at around US$39.76 is a bargain or already priced for perfection, this breakdown is aimed at you. The stock has returned 4.4% over the last week and 6.1% over the last month, while the 1 year return sits at a 7.2% decline and the 5 year return is 16.3%. Recent market attention on regional banks and their balance sheet strength has kept names like First Merchants in focus, particularly among investors comparing financial health and profitability...
NYSE:ES
NYSE:ESElectric Utilities

Eversource Exit From Offshore Wind Recasts Focus On Regulated Earnings

Eversource Energy (NYSE:ES) is exiting its offshore wind partnership with Orsted. The company plans to refocus on its core regulated utility operations following this exit. This change affects how Eversource allocates capital between renewables projects and regulated businesses. Eversource Energy runs regulated electric, gas, and water utilities, which typically follow defined rate frameworks set by regulators. Stepping away from the offshore wind joint venture signals a preference for...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Is Fox (FOXA) Still Attractive After A 43.5% One Year Share Price Jump

If you are wondering whether Fox shares still offer value after recent gains, this article will walk through what the current price could be implying about the company. Fox closed at US$72.78, with returns of 43.5% over 1 year and 147.2% over 5 years. This is the case even though the stock is roughly flat over the last month and year to date. Recent price moves sit against a backdrop of ongoing interest in US media groups and how they position themselves across traditional TV and digital...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Is Nasdaq (NDAQ) Pricing Look Justified After Strong Multi Year Share Gains?

If you are asking whether Nasdaq stock looks reasonably priced or stretched right now, you are in the right place for a clear, valuation focused look at the numbers. The share price closed at US$96.89 recently, with returns of 19.1% over 1 year, 67.0% over 3 years and 118.2% over 5 years. Shorter term moves of a 1.2% decline over 7 days and a 0.2% decline over 30 days show a more muted picture. Recent coverage has focused on Nasdaq's role in capital markets infrastructure and ongoing...
NYSE:CNH
NYSE:CNHMachinery

CNH Industrial’s R4 Robot Extends Automation Push Into Specialty Crop Services

CNH Industrial (NYSE:CNH) has introduced its R4 autonomous robot, aimed at addressing labor shortages in specialty crop farming. The launch focuses on automated solutions for tasks in high value crops where finding and retaining workers can be difficult. This move builds on CNH Industrial's broader push into automation and robotics within agriculture equipment. For you as an investor, the R4 robot sits at the intersection of machinery, software, and farm operations, an area that has been...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Is Tilray Brands' (TLRY) Italian Medical Push Quietly Redefining Its Global Cannabis Strategy?

Earlier in January 2026, Tilray Medical, a division of Tilray Brands, expanded its European medical cannabis operations by launching Tilray Medical Italia, rebranding the former FL Group and broadening an Italian Ministry of Health–authorized product portfolio in partnership with Molteni Farmaceutici. This move not only deepens Tilray’s presence in one of Europe’s most tightly regulated medical cannabis markets, it also advances its goal of building a unified global medical cannabis platform...
NYSE:MOH
NYSE:MOHHealthcare

A Look At Molina Healthcare (MOH) Valuation After Medicare Advantage Payment Shock And Guidance Pressure

The Molina Healthcare (MOH) share move was driven by a policy shock after the Centers for Medicare & Medicaid Services proposed just a 0.09% net payment increase for 2027 Medicare Advantage plans. See our latest analysis for Molina Healthcare. At a share price of US$179.59, Molina’s recent 1 day share price return of a 2.89% decline and 7 day share price return of an 11.05% decline sit against a 90 day share price return of 17.33%. The 1 year total shareholder return of a 42.14% decline...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

CorMedix Analyst Day Highlights Infection Prevention Plans For REZZAYO And DefenCath

CorMedix (NasdaqGM:CRMD) is hosting an analyst day focused on its late stage clinical programs. The event will feature updates on REZZAYO for fungal infection prophylaxis and DefenCath for catheter related bloodstream infection prevention. Management is expected to outline current program status and broader business direction for these key assets. For investors watching CorMedix, the focus is on how these late stage assets fit into the broader infection prevention space. REZZAYO and...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Is Travere Therapeutics (TVTX) Offering Value After Recent Share Price Swings?

If you are wondering whether Travere Therapeutics at around US$31.09 is offering fair value or an opportunity, you are not alone. This article is built to help you size that up clearly. The stock has had a mixed run, with a 5.6% gain over the last 7 days but an 18.6% decline over 30 days, while still sitting on a 52.0% return over 1 year and 43.1% over 3 years, compared with a 2.1% decline over 5 years. Recent coverage of Travere Therapeutics has focused on its position in the...